390 related articles for article (PubMed ID: 29896857)
1. Diagnosis of invasive mold diseases in patients with hematological malignancies using Aspergillus, Mucorales, and panfungal PCR in BAL.
Wehrle-Wieland E; Affolter K; Goldenberger D; Tschudin Sutter S; Halter J; Passweg J; Tamm M; Khanna N; Stolz D
Transpl Infect Dis; 2018 Oct; 20(5):e12953. PubMed ID: 29896857
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of invasive fungal infections in haematological patients by combined use of galactomannan, 1,3-β-D-glucan, Aspergillus PCR, multifungal DNA-microarray, and Aspergillus azole resistance PCRs in blood and bronchoalveolar lavage samples: results of a prospective multicentre study.
Boch T; Spiess B; Cornely OA; Vehreschild JJ; Rath PM; Steinmann J; Heinz WJ; Hahn J; Krause SW; Kiehl MG; Egerer G; Liebregts T; Koldehoff M; Klein M; Nolte F; Mueller MC; Merker N; Will S; Mossner M; Popp H; Hofmann WK; Reinwald M; Buchheidt D
Clin Microbiol Infect; 2016 Oct; 22(10):862-868. PubMed ID: 27393123
[TBL] [Abstract][Full Text] [Related]
3. A Comparison of Aspergillus and Mucorales PCR Testing of Different Bronchoalveolar Lavage Fluid Fractions from Patients with Suspected Invasive Pulmonary Fungal Disease.
Springer J; White PL; Kessel J; Wieters I; Teschner D; Korczynski D; Liebregts T; Cornely OA; Schwartz S; Elgeti T; Meintker L; Krause SW; Posso RB; Heinz WJ; Fuhrmann S; Vehreschild JJ; Einsele H; Rickerts V; Loeffler J
J Clin Microbiol; 2018 Feb; 56(2):. PubMed ID: 29187564
[TBL] [Abstract][Full Text] [Related]
4. Improving the diagnosis of invasive aspergillosis by the detection of Aspergillus in broncho-alveolar lavage fluid: Comparison of non-culture-based assays.
Guegan H; Robert-Gangneux F; Camus C; Belaz S; Marchand T; Baldeyrou M; Gangneux JP
J Infect; 2018 Feb; 76(2):196-205. PubMed ID: 29248586
[TBL] [Abstract][Full Text] [Related]
5. Galactomannan testing and Aspergillus PCR in same-day bronchoalveolar lavage and blood samples for diagnosis of invasive aspergillosis.
Eigl S; Hoenigl M; Spiess B; Heldt S; Prattes J; Neumeister P; Wolfler A; Rabensteiner J; Prueller F; Krause R; Reinwald M; Flick H; Buchheidt D; Boch T
Med Mycol; 2017 Jul; 55(5):528-534. PubMed ID: 27744310
[TBL] [Abstract][Full Text] [Related]
6. Clinical utility of Aspergillus galactomannan and PCR in bronchoalveolar lavage fluid for the diagnosis of invasive pulmonary aspergillosis in patients with haematological malignancies.
Heng SC; Chen SC; Morrissey CO; Thursky K; Manser RL; De Silva HD; Halliday CL; Seymour JF; Nation RL; Kong DC; Slavin MA
Diagn Microbiol Infect Dis; 2014 Jul; 79(3):322-7. PubMed ID: 24768294
[TBL] [Abstract][Full Text] [Related]
7. Aspergillus galactomannan enzyme immunoassay and quantitative PCR for diagnosis of invasive aspergillosis with bronchoalveolar lavage fluid.
Musher B; Fredricks D; Leisenring W; Balajee SA; Smith C; Marr KA
J Clin Microbiol; 2004 Dec; 42(12):5517-22. PubMed ID: 15583275
[TBL] [Abstract][Full Text] [Related]
8. Diagnosing pulmonary aspergillosis in patients with hematological malignancies: a multicenter prospective evaluation of an Aspergillus PCR assay and a galactomannan ELISA in bronchoalveolar lavage samples.
Reinwald M; Spiess B; Heinz WJ; Vehreschild JJ; Lass-Flörl C; Kiehl M; Schultheis B; Krause SW; Wolf HH; Bertz H; Maschmeyer G; Hofmann WK; Buchheidt D
Eur J Haematol; 2012 Aug; 89(2):120-7. PubMed ID: 22650156
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of risk factors for invasive pulmonary aspergillosis and detection of diagnostic values of galactomannan and PCR methods in bronchoalveolar lavage samples from non-neutropenic intensive care unit patients].
Özger S; Hızel K; Kalkancı A; Aydoğdu M; Civil F; Dizbay M; Gürsel G
Mikrobiyol Bul; 2015 Oct; 49(4):565-75. PubMed ID: 26649414
[TBL] [Abstract][Full Text] [Related]
10. Conventional PCR as a reliable method for diagnosing invasive mucormycosis in resource-limited settings.
Pandey M; Xess I; Singh G; Kumar R; Mahapatra M; Jyotsna VP; Agarwal R; Ghosh A; Iram A; Mani P
J Med Microbiol; 2021 May; 70(5):. PubMed ID: 34038342
[No Abstract] [Full Text] [Related]
11. Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.
Hoenigl M; Prattes J; Spiess B; Wagner J; Prueller F; Raggam RB; Posch V; Duettmann W; Hoenigl K; Wölfler A; Koidl C; Buzina W; Reinwald M; Thornton CR; Krause R; Buchheidt D
J Clin Microbiol; 2014 Jun; 52(6):2039-45. PubMed ID: 24671798
[TBL] [Abstract][Full Text] [Related]
12. Galactomannan testing in bronchoalveolar lavage fluid facilitates the diagnosis of invasive pulmonary aspergillosis in patients with hematologic malignancies and stem cell transplant recipients.
Nguyen MH; Leather H; Clancy CJ; Cline C; Jantz MA; Kulkarni V; Wheat LJ; Wingard JR
Biol Blood Marrow Transplant; 2011 Jul; 17(7):1043-50. PubMed ID: 21087680
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic role of polymerase chain reaction in bronchoalveolar lavage fluid for invasive pulmonary aspergillosis in immunocompromised patients - A retrospective cohort study.
Hardak E; Fuchs E; Leskes H; Geffen Y; Zuckerman T; Oren I
Int J Infect Dis; 2019 Jun; 83():20-25. PubMed ID: 30926540
[TBL] [Abstract][Full Text] [Related]
14. Screening of invasive fungal infections by a real-time panfungal (pan-ACF) polymerase chain reaction assay in patients with haematological malignancy.
Capoor MR; Puri S; Raheja H; Mohindra R; Gupta DK; Verma PK; Chowdhary R
Indian J Med Microbiol; 2017; 35(1):41-47. PubMed ID: 28303817
[TBL] [Abstract][Full Text] [Related]
15. Quantitative PCR (qPCR) Detection of Mucorales DNA in Bronchoalveolar Lavage Fluid To Diagnose Pulmonary Mucormycosis.
Scherer E; Iriart X; Bellanger AP; Dupont D; Guitard J; Gabriel F; Cassaing S; Charpentier E; Guenounou S; Cornet M; Botterel F; Rocchi S; Berceanu A; Millon L
J Clin Microbiol; 2018 Aug; 56(8):. PubMed ID: 29875192
[TBL] [Abstract][Full Text] [Related]
16. Dynamics and prognostic value of plasma cell-free DNA PCR in patients with invasive aspergillosis and mucormycosis.
Moreno A; Mah J; Budvytiene I; Ho DY; Schwenk HT; Banaei N
J Clin Microbiol; 2024 May; 62(5):e0039424. PubMed ID: 38602412
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic Efficacy of Aspergillus Galactomannan Lateral Flow Assay in Patients with Hematological Malignancies: A Prospective Multicenter Study.
Alhan O; Saba R; Akalin EH; Ener B; Ture Yuce Z; Deveci B; Guncu MM; Kahveci HN; Yilmaz AF; Odabasi Z
Mycopathologia; 2023 Oct; 188(5):643-653. PubMed ID: 37273172
[TBL] [Abstract][Full Text] [Related]
18. PCR with electrospray ionization-mass spectrometry on bronchoalveolar lavage for detection of invasive mold infections in hematological patients.
Krifors A; Özenci V; Ullberg M; Ackefors M; Jädersten M; Strålin K; Blennow O
PLoS One; 2019; 14(2):e0212812. PubMed ID: 30794675
[TBL] [Abstract][Full Text] [Related]
19. Use of Aspergillus fumigatus real-time PCR in bronchoalveolar lavage samples (BAL) for diagnosis of invasive aspergillosis, including azole-resistant cases, in high risk haematology patients: the need for a combined use with galactomannan.
Mikulska M; Furfaro E; De Carolis E; Drago E; Pulzato I; Borghesi ML; Zappulo E; Raiola AM; Grazia CD; Del Bono V; Cittadini G; Angelucci E; Sanguinetti M; Viscoli C
Med Mycol; 2019 Nov; 57(8):987-996. PubMed ID: 30753590
[TBL] [Abstract][Full Text] [Related]
20. Therapy with antifungals decreases the diagnostic performance of PCR for diagnosing invasive aspergillosis in bronchoalveolar lavage samples of patients with haematological malignancies.
Reinwald M; Hummel M; Kovalevskaya E; Spiess B; Heinz WJ; Vehreschild JJ; Schultheis B; Krause SW; Claus B; Suedhoff T; Schwerdtfeger R; Reuter S; Kiehl MG; Hofmann WK; Buchheidt D
J Antimicrob Chemother; 2012 Sep; 67(9):2260-7. PubMed ID: 22740590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
